
Number of publications published per year by Villanueva, Candid. (Source : PubMed)

Distribution of publications types for Villanueva, Candid. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer.
Br. J. Cancer
2010;102;5
Safety profile of new anticancer drugs.
Expert Opin Drug Saf
2010;9;2
Response rates: a valuable signal of promising activity?
Cancer J
2009;15;5


Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
Gut
2009;58;8
The detection of brain ischaemia in rats by inductive phase shift spectroscopy.
Physiol Meas
2009;30;8

Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Gastroenterology
2009;137;1

Ixabepilone: a new active chemotherapy in the treatment of breast cancer.
Women's health (London, England)
2009;5;2


Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy.
Aliment. Pharmacol. Ther.
2009;29;4
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.
Clin. Gastroenterol. Hepatol.
2008;6;12


Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study.
Ann. Oncol.
2008;19;11
[ See timeline ] [ See all publications ]
means that Villanueva, Candid has 17 papers cited a least 17 times - methodology
Oncologie Médicale, CHU J Minjoz, 25000 Besançon, France.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.